Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

Promoting Precision Cancer Medicine through a Community-Driven Knowledgebase.

Geifman N, Haviv I, Kurzrock R, Rubin E.

J Pers Med. 2014 Dec 15;4(4):475-88. doi: 10.3390/jpm4040475.

2.

A novel role for the Pol I transcription factor UBTF in maintaining genome stability through the regulation of highly transcribed Pol II genes.

Sanij E, Diesch J, Lesmana A, Poortinga G, Hein N, Lidgerwood G, Cameron DP, Ellul J, Goodall GJ, Wong LH, Dhillon AS, Hamdane N, Rothblum LI, Pearson RB, Haviv I, Moss T, Hannan RD.

Genome Res. 2015 Feb;25(2):201-12. doi: 10.1101/gr.176115.114. Epub 2014 Dec 1.

3.

Effects of Tamoxifen and oestrogen on histology and radiographic density in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers.

Chew GL, Huo CW, Huang D, Blick T, Hill P, Cawson J, Frazer H, Southey MC, Hopper JL, Britt K, Henderson MA, Haviv I, Thompson EW.

Breast Cancer Res Treat. 2014 Nov;148(2):303-14. doi: 10.1007/s10549-014-3169-2. Epub 2014 Oct 21.

PMID:
25332094
4.

Canonical androstenedione reduction is the predominant source of signaling androgens in hormone-refractory prostate cancer.

Fankhauser M, Tan Y, Macintyre G, Haviv I, Hong MK, Nguyen A, Pedersen JS, Costello AJ, Hovens CM, Corcoran NM.

Clin Cancer Res. 2014 Nov 1;20(21):5547-57. doi: 10.1158/1078-0432.CCR-13-3483. Epub 2014 Apr 25.

PMID:
24771644
5.

Vascular histone deacetylation by pharmacological HDAC inhibition.

Rafehi H, Balcerczyk A, Lunke S, Kaspi A, Ziemann M, Kn H, Okabe J, Khurana I, Ooi J, Khan AW, Du XJ, Chang L, Haviv I, Keating ST, Karagiannis TC, El-Osta A.

Genome Res. 2014 Aug;24(8):1271-84. doi: 10.1101/gr.168781.113. Epub 2014 Apr 14.

6.

Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cells.

Diesch J, Sanij E, Gilan O, Love C, Tran H, Fleming NI, Ellul J, Amalia M, Haviv I, Pearson RB, Tulchinsky E, Mariadason JM, Sieber OM, Hannan RD, Dhillon AS.

PLoS One. 2014 Mar 21;9(3):e88950. doi: 10.1371/journal.pone.0088950. eCollection 2014.

7.

A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal response.

Busuttil RA, George J, Tothill RW, Ioculano K, Kowalczyk A, Mitchell C, Lade S, Tan P, Haviv I, Boussioutas A.

Clin Cancer Res. 2014 May 15;20(10):2761-72. doi: 10.1158/1078-0432.CCR-13-3049. Epub 2014 Mar 21.

PMID:
24658156
8.

BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.

Safra T, Lai WC, Borgato L, Nicoletto MO, Berman T, Reich E, Alvear M, Haviv I, Muggia FM.

Ann Oncol. 2013 Nov;24 Suppl 8:viii63-viii68. doi: 10.1093/annonc/mdt315.

9.

Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes.

Meikle PJ, Wong G, Barlow CK, Weir JM, Greeve MA, MacIntosh GL, Almasy L, Comuzzie AG, Mahaney MC, Kowalczyk A, Haviv I, Grantham N, Magliano DJ, Jowett JB, Zimmet P, Curran JE, Blangero J, Shaw J.

PLoS One. 2013 Sep 27;8(9):e74341. doi: 10.1371/journal.pone.0074341. eCollection 2013.

10.

Dynamic changes in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers during various murine peripartum states and over time.

Chew GL, Huang D, Huo CW, Blick T, Hill P, Cawson J, Frazer H, Southey MD, Hopper JL, Henderson MA, Haviv I, Thompson EW.

Breast Cancer Res Treat. 2013 Jul;140(2):285-97. doi: 10.1007/s10549-013-2642-7. Epub 2013 Jul 24.

PMID:
23881524
11.

Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.

Choudhury S, Almendro V, Merino VF, Wu Z, Maruyama R, Su Y, Martins FC, Fackler MJ, Bessarabova M, Kowalczyk A, Conway T, Beresford-Smith B, Macintyre G, Cheng YK, Lopez-Bujanda Z, Kaspi A, Hu R, Robens J, Nikolskaya T, Haakensen VD, Schnitt SJ, Argani P, Ethington G, Panos L, Grant M, Clark J, Herlihy W, Lin SJ, Chew G, Thompson EW, Greene-Colozzi A, Richardson AL, Rosson GD, Pike M, Garber JE, Nikolsky Y, Blum JL, Au A, Hwang ES, Tamimi RM, Michor F, Haviv I, Liu XS, Sukumar S, Polyak K.

Cell Stem Cell. 2013 Jul 3;13(1):117-30. doi: 10.1016/j.stem.2013.05.004. Epub 2013 Jun 13.

12.

A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling.

Chen YC, Bui AV, Diesch J, Manasseh R, Hausding C, Rivera J, Haviv I, Agrotis A, Htun NM, Jowett J, Hagemeyer CE, Hannan RD, Bobik A, Peter K.

Circ Res. 2013 Jul 19;113(3):252-65. doi: 10.1161/CIRCRESAHA.113.301562. Epub 2013 Jun 7.

13.

Determining epithelial contribution to in vivo mesenchymal tumour expression signature using species-specific microarray profiling analysis of xenografts.

Purdom E, Restall C, Busuttil RA, Schluter H, Boussioutas A, Thompson EW, Anderson RL, Speed TP, Haviv I.

Genet Res (Camb). 2013 Feb;95(1):14-29. doi: 10.1017/S0016672313000013. Epub 2013 Mar 18.

PMID:
23497823
14.

Discovery and analysis of consistent active sub-networks in cancers.

Gaire RK, Smith L, Humbert P, Bailey J, Stuckey PJ, Haviv I.

BMC Bioinformatics. 2013;14 Suppl 2:S7. doi: 10.1186/1471-2105-14-S2-S7. Epub 2013 Jan 21.

15.

High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers.

Chew GL, Huang D, Lin SJ, Huo C, Blick T, Henderson MA, Hill P, Cawson J, Morrison WA, Campbell IG, Hopper JL, Southey MC, Haviv I, Thompson EW.

Breast Cancer Res Treat. 2012 Aug;135(1):177-87. doi: 10.1007/s10549-012-2128-z. Epub 2012 Jun 23.

PMID:
22729891
16.

Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers.

Yan M, Xu H, Waddell N, Shield-Artin K, Haviv I; kConFab authors, McKay MJ, Fox SB.

Breast Cancer Res. 2012 Apr 26;14(2):R69.

17.

Soiling the seed: microenvironment and epithelial mesenchymal plasticity.

Haviv I, Thompson EW.

Cancer Microenviron. 2012 Apr;5(1):1-3. doi: 10.1007/s12307-012-0104-0. No abstract available.

18.

Vascular normalization by loss of Siah2 results in increased chemotherapeutic efficacy.

Wong CS, Sceneay J, House CM, Halse HM, Liu MC, George J, Hunnam TC, Parker BS, Haviv I, Ronai Z, Cullinane C, Bowtell DD, Möller A.

Cancer Res. 2012 Apr 1;72(7):1694-704. doi: 10.1158/0008-5472.CAN-11-3310. Epub 2012 Feb 21.

19.

Plasma lipidomic analysis of stable and unstable coronary artery disease.

Meikle PJ, Wong G, Tsorotes D, Barlow CK, Weir JM, Christopher MJ, MacIntosh GL, Goudey B, Stern L, Kowalczyk A, Haviv I, White AJ, Dart AM, Duffy SJ, Jennings GL, Kingwell BA.

Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2723-32. doi: 10.1161/ATVBAHA.111.234096.

20.

The social aspects of EMT-MET plasticity.

Thompson EW, Haviv I.

Nat Med. 2011 Sep 7;17(9):1048-9. doi: 10.1038/nm.2437. No abstract available.

PMID:
21900919
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk